Mid-Atlantic BioTherapeutics

Doylestown, United States

Mid-Atlantic BioTherapeutics is a Clinical-stage Pharmaceutical Company.

Aug 2025

Venture - Series Unknown

Life Science Pharmaceutical

Top Investors

SMITM Capital Markets Legend Innovation Life Science Fund

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Mid-Atlantic BioTherapeutics

Who are Mid-Atlantic BioTherapeutics's investors?

Mid-Atlantic BioTherapeutics's investors include SMITM Capital Markets, Legend Innovation Life Science Fund.

Where is Mid-Atlantic BioTherapeutics headquartered?

Mid-Atlantic BioTherapeutics is headquartered in Doylestown, United States.

What does Mid-Atlantic BioTherapeutics do?

Mid-Atlantic BioTherapeutics is a Clinical-stage Pharmaceutical Company.

What stage is Mid-Atlantic BioTherapeutics at?

Mid-Atlantic BioTherapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 23, 2025.

MLA

"Mid-Atlantic BioTherapeutics — Funding & Investors." VCBacked, August 23, 2025, https://www.vcbacked.co/company/mid-atlantic-biotherapeutics. Accessed July 2, 2026.

APA

VCBacked. (2025). Mid-Atlantic BioTherapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/mid-atlantic-biotherapeutics

Wikipedia (cite web)

{{cite web |title=Mid-Atlantic BioTherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mid-atlantic-biotherapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 23, 2025.